[1]江海林,孟小茜,廖华强,等.不同体位经桡动脉途径行TACE术的透视时间对比[J].介入放射学杂志,2021,30(03):275-278.
 JIANG Hailin,MENG Xiaoxi,LIAO Huaqiang,et al.Comparison of fluoroscopic time between different body positions in performing TACE via radial approach[J].journal interventional radiology,2021,30(03):275-278.
点击复制

不同体位经桡动脉途径行TACE术的透视时间对比()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
30
期数:
2021年03
页码:
275-278
栏目:
临床研究
出版日期:
2021-03-29

文章信息/Info

Title:
Comparison of fluoroscopic time between different body positions in performing TACE via radial approach
作者:
江海林 孟小茜 廖华强 刘洪超 顾亚峰 董伟华 刘士远
Author(s):
JIANG Hailin MENG Xiaoxi LIAO Huaqiang LIU Hongchao GU Yafeng DONG Weihua LIU Shiyuan.
Department of Interventional Radiology, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
关键词:
【关键词】 肝癌 肝动脉化疗栓塞术 经桡动脉途径 透视时间
文献标志码:
A
摘要:
【摘要】 目的 比较不同体位经桡动脉途径及经股动脉途径行TACE术的透视时间。方法 对120例首次行TACE术的肝癌患者,按照体位及入路途径不同随机分成四组,每组30例。A组左上臂外展,经左侧桡动脉途径穿刺;B组左手置于左侧腹股沟处,经左侧桡动脉途径穿刺;C组经右侧桡动脉途径;D组经右侧股动脉途径。记录手术中插管至腹腔干的透视时间、总的透视时间。比较4组间差异。结果 插管至腹腔干透视时间分别为A组(47.47±36.12) s,B组(53.57±21.32) s,C组(76.03±45.22) s,D组(40.30±28.30) s,差异具统计学(P=0.001)。总透视时间分别为A组(740.20±486.04) s、B组(732.67±409.35) s、C组(784.60±271.54) s、D组(759.94±425.82) s,差异无统计学意义(P=0.948)。结论 不同体位经桡动脉途径及经股动脉途径行TACE术在总的透视时间上均无差异,经右侧桡动脉途径插管至腹腔干所需透视时间更长。

参考文献/References:

[1] Feng RM, Zong YN, Cao SM,et al. Current cancer situation in China: good or bad news from the 2018 global cancer statistics?[J]. Cancer Commun(Lond), 2019, 39:22.
[2] 吴孟超,汤钊猷,刘允怡,等. 原发性肝癌诊疗规范(2019年版)[J]. 中国实用外科杂志, 2020, 40:121-138.
[3] Wu T, Sun R, Huang Y, et al. Transradial arterial chemoembo-lization reduces complications and costs in patients with hepatocellular carcinoma[J]. Indian J Cancer, 2015, 52(Suppl 2):e107-e111.
[4] Posham R, Biederman DM, Patel RS, et al.Transradial approach for noncoronary interventions: a single-center review of safety and feasibility in the first 1,500 cases[J]. J Vasc Interv Radiol, 2016, 27:159-166.
[5] 胡晓钢,杨晓仙,郭晓华,等. 经桡动脉途径前列腺动脉栓塞术可行性及安全性研究[J]. 介入放射学杂志, 2017, 26:399-402.
[6] 江海林,孟小茜,廖华强. 等:经桡动脉途径行外周介入的安全性与可行性[J]. 介入放射学杂志, 2018, 27:21-24.
[7] Kis B, Mills M, Hoffe SE. Hepatic radioembolization from transradial access: initial experience and comparison to transfemoral access[J]. Diagn Interv Radiol, 2016, 22:444-449.
[8] Bishay VL, Biederman DM, Ward TJ, et al. Transradial approach for hepatic radioembolization: initial results and technique[J]. AJR Am J Roentgenol, 2016, 207:1112-1121.
[9] Fischman AM, Swinburne NC, Patel RS. A technical guide describing the use of transradial access technique for endova-scular interventions[J]. Tech Vasc Interv Radiol , 2015,18:58- 65.
[10] Hung, Lee EW, McWilliams JP, et al. A reality check in transradial access: a single-centre comparison of transradial and transfemoral access for abdominal and peripheral intervention[J]. Eur Radiol, 2018, 29:68-74.
[11] Becher T, Behnes M, Unsal M,et al. Radiation exposure and contrast agent use related to radial versus femoral arterial access during percutaneous coronary intervention(PCI): results of the FERARI study[J]. Cardiovasc Revasc Med, 2016, 17:505-509.
[12] Loewenstern J, Welch C, Lekperic S, et al. Patient radiation exposure in transradial versus transfemoral yttrium- 90 radioembo-lization: a retrospective propensity score- matched analysis[J]. J Vasc Interv Radiol, 2018, 29:936-942.
[13] Brener MI, Bush A, Miller JM, et al.Influence of radial versus femoral access site on coronary angiography and intervention outcomes: a systematic review and meta- analysis[J]. Catheter Cardiovasc Interv, 2017, 90:1093-1104.
[14] Mortensen C, Chung J, Liu D, et al. Prospective study on total fluoroscopic time in patients undergoing uterine artery embo-lization: comparing ttransradial and transfemoral approaches[J]. Cardiovasc Intervent Radiol, 2018, 42:441- 447.
[15] Chen YY, Liu P, Wu YS, et al.Transradial vs transfemoral access in patients with hepatic malignancy and undergoing hepatic interventions: a systematic review and meta- analysis[J]. Medicine(Baltimore), 2018, 97:e13926.
[16] Bernat I, Aminian A, Pancholy S, et al. Best practices for the prevention of radial artery occlusion after transradial diagnostic angiography and intervention: an international consensus paper[J]. JACC Cardiovasc Interv, 2019, 12:2235-2246

相似文献/References:

[1]叶更新,曾文,杜德坤,等.肝动脉栓塞与经皮碘油标记酒精注射联合治疗晚期肝癌[J].介入放射学杂志,1996,(01):42.
[2]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
 .The volume of Lipiodol used in TACE: its current situation and research progress [J].journal interventional radiology,2012,(03):348.
[3]施长杲,吕维富,鲁 东,等.肝动脉化疗栓塞术后并发肝脓肿5例治疗分析[J].介入放射学杂志,2011,(04):273.
 SHI Chang-gao,LV Wei-fu,LU Dong,et al.The treatment of liver abscess occurred after transcatheter arterial chemoembolization report of five cases[J].journal interventional radiology,2011,(03):273.
[4]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗30例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
 ,,et al.TACE combined with radiofrequency ablation for massive primary hepatocellular carcinomas: a clinical therapeutic evaluation [J].journal interventional radiology,2012,(03):322.
[5]张   磊,陆骊工,李   勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
 ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].journal interventional radiology,2011,(03):968.
[6]敖 劲,张跃伟,徐 克. 明胶海绵微粒经动脉栓塞治疗原发性肝癌的研究现状[J].介入放射学杂志,2011,(12):1010.
 AO Jin,ZHANG Yue-wei,XU Ke..Gelatin sponge particle used as an embolic agent in transcatheter arterial chemoembolization treatment for primary hepatocellular carcinoma: its current situation in research[J].journal interventional radiology,2011,(03):1010.
[7]杜丹丹,吕维富. 肝癌射频消融后的影像学评价[J].介入放射学杂志,2012,(01):75.
 DU Dan dan,Lv Wei fu..Imaging evaluation of liver cancer after radiofrequency ablation therapy[J].journal interventional radiology,2012,(03):75.
[8]赵 艳,韩国宏,白 苇,等. 药物缓释微球肝动脉化疗栓塞治疗肝癌研究进展[J].介入放射学杂志,2012,(01):78.
 ZHAO Yan,HAN Guo-hong,BAI Wei,et al.Transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma: its research progress[J].journal interventional radiology,2012,(03):78.
[9]何海涛,刘 圣,刘建秦,等. 肝癌TACE术并发脑碘油栓塞二例并文献复习[J].介入放射学杂志,2012,(08):682.
 HE Hai- tao,LIU sheng,LIU Jian- qing,et al. Cerebral Lipiodol embolism occurred after transcatheter arterial chemoembolization for hepatocellular carcinoma: report of two cases with literature review[J].journal interventional radiology,2012,(03):682.
[10]刘纪营,马 南,管 生,等. 预防性应用抗生素的不同方法对介入治疗并发肝脓肿的影响[J].介入放射学杂志,2013,(06):474.
 LIU Ji? ying,MA Nan,GUAN Sheng,et al. The influence of different using methods of antibiotic prophylaxis on the occurrence of liver abscess after transcatheter hepatic arterial chemoembolization[J].journal interventional radiology,2013,(03):474.
[11]纪建红,郑群丽,陈思倩,等.TACE联合射频消融术治疗巨块型肝癌的护理[J].介入放射学杂志,2013,(12):1052.
 JI Jian? hong,ZHENG Qun? li,CHEN Si? qian,et al.Nursing care for patients with massive hepatocellular carcinoma receiving combination therapy of TACE and radiofrequency ablation[J].journal interventional radiology,2013,(03):1052.
[12]臧 爽,徐 阳,梁松年.原发性肝癌患者经肝动脉化疗栓塞术后住院天数影响因素的多元线性回归分析[J].介入放射学杂志,2015,(01):80.
 ZANG Shuang,XU Yang,LIANG Song nian..Multiple linear regression analysis of factors related to the hospitalization days in HCC patients after transcatheter hepatic arterial chemoembolization[J].journal interventional radiology,2015,(03):80.
[13]任文君,王泽阳,黄 欣,等.肝动脉化疗栓塞术联合125I放射性粒子植入术与单独肝动脉化疗栓塞术治疗肝癌的meta分析[J].介入放射学杂志,2019,28(02):132.
 REN Wenjun,WANG Zeyang,HUANG Xin,et al.TACE combined with 125I seed implantation vs simple TACE for the treatment of liver cancer: a meta analysis[J].journal interventional radiology,2019,28(03):132.
[14]赵凯凯,司友娇,黄九宁,等.肝癌患者TACE术后对比剂肾病的危险因素[J].介入放射学杂志,2019,28(10):942.
 ZHAO Kaikai,SI Youjiao,HUANG Jiuning,et al.The risk factors for contrast- induced nephropathy in patients with HCC after TACE[J].journal interventional radiology,2019,28(03):942.

备注/Memo

备注/Memo:
(收稿日期:2020-10- 08)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2021-03-25